B7-homolog 3 (B7-H3) alias CD276, a member of the B7 family of immune checkpoint inhibitors, is expressed in cases of hematological cancers and solid tumors including higher grades of glioma. This evidence concerns the gene CD276 and hematopoietic and lymphoid cell neoplasm.